APA (7th ed.) Citation

D, T., HH, H., R, K., YC, H., HP, T., CC, L., . . . CH, Y. (2022). The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma. Medicina (Kaunas, Lithuania), 58(2), . https://doi.org/10.3390/medicina58020212

Chicago Style (17th ed.) Citation

D, Tseeleesuren, Hsiao HH, Kant R, Huang YC, Tu HP, Lai CC, Huang SF, and Yen CH. "The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma." Medicina (Kaunas, Lithuania) 58, no. 2 (2022). https://doi.org/10.3390/medicina58020212.

MLA (9th ed.) Citation

D, Tseeleesuren, et al. "The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma." Medicina (Kaunas, Lithuania), vol. 58, no. 2, 2022, https://doi.org/10.3390/medicina58020212.